Isofol Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Net Income	-43.49	-37.07	-159.79	-200.25	-188.99	Upgrade
Depreciation & Amortization	0	0.04	0.07	1.6	1.77	Upgrade
Other Operating Activities	-0.26	-4.45	-1.28	-4.54	2.19	Upgrade
Change in Accounts Receivable	0.19	21.23	-0.5	9.86	-14.05	Upgrade
Change in Other Net Operating Assets	1.57	-32.29	-31.17	4.91	38.81	Upgrade
Operating Cash Flow	-41.99	-52.54	-192.68	-188.43	-160.27	Upgrade
Sale of Property, Plant & Equipment	-	0.05	-	-	-	Upgrade
Investment in Securities	-	0.05	-	-	-	Upgrade
Investing Cash Flow	-	0.1	-	-	-	Upgrade
Long-Term Debt Repaid	-	-	-	-1.55	-1.55	Upgrade
Net Debt Issued (Repaid)	-	-	-	-1.55	-1.55	Upgrade
Issuance of Common Stock	-	-	-	500.16	151.26	Upgrade
Other Financing Activities	-	-	0.02	-48.13	0.31	Upgrade
Financing Cash Flow	-	-	0.02	450.48	150.01	Upgrade
Foreign Exchange Rate Adjustments	-0.01	0.05	3.79	1.01	-0.33	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	0	-	-	Upgrade
Net Cash Flow	-41.99	-52.39	-188.87	263.06	-10.59	Upgrade
Free Cash Flow	-41.99	-52.54	-192.68	-188.43	-160.27	Upgrade
Free Cash Flow Margin	-	-7286.55%	-1505.66%	-840.94%	-431.77%	Upgrade
Free Cash Flow Per Share	-0.26	-0.33	-1.19	-1.50	-2.61	Upgrade
Cash Interest Paid	-	-	-	0.17	1.74	Upgrade
Cash Income Tax Paid	-	-	-	-	0	Upgrade
Levered Free Cash Flow	-27.75	-41.54	-139.64	-114.98	-87.22	Upgrade
Unlevered Free Cash Flow	-27.75	-41.53	-139.64	-114.88	-87.13	Upgrade
Change in Net Working Capital	-1.76	15.52	34.99	-11.32	-27.66	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.